Jimmy, E.O. and Okon, M.A. (2012) Periodic Validation of High Antidiabetic Potentials of Unripe Plantain in Comparison with Glibenclamide and Fansidar. American Journal of Pharmacology and Toxicology, 7, 15-18.
https://doi.org/10.3844/ajptsp.2012.15.18

has been cited by the following article:

• TITLE: Durational Therapeutic Dose of Fansidar: A Functional Index in Its Antidiabetic Properties

  AUTHORS: E. O. Jimmy

  KEYWORDS: Durational Dosage, Diabetes, Antidiabetic Potentials

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.7 No.1, January 4, 2019

  ABSTRACT: Effects of fansidar in alloxan-induced diabetes were investigated in thirty (30) male and female albino rats for 28 days. The results showed a steady weekly decrease in blood glucose concentration in induced diabetic rats after fansidar treatment. In week 1, i.e. 7 days, there was significant difference in the blood glucose levels between the control and diabetic rats (P i.e. high glucose concentration, same in week II i.e. 14 days. However, in day 21 i.e. week III there was a significant reduction in the blood glucose concentration compared with control P i.e. in 28 days treatment. The result has shown that fansidar has antidiabetic potentials on long term durational administration.